Moolec Science (MLEC) Liabilities and Shareholders Equity (2022 - 2026)

Moolec Science has disclosed Liabilities and Shareholders Equity across 5 years of filings, most recently posting $104.2 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $104.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $443.7 million (changed N/A YoY), and the FY2025 annual result was $204.7 million, down 78.45% from the prior year.
• Liabilities and Shareholders Equity came in at $104.2 million for Q1 2026 at Moolec Science, up from $103.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $949.8 million in Q2 2024 to a low of $5.7 million in Q2 2022.
• The 5-year median for Liabilities and Shareholders Equity is $26.0 million (2024), against an average of $119.7 million.
• Across the five-year window, Liabilities and Shareholders Equity jumped 3849.21% in 2024 and slumped 78.45% in 2025, its largest moves.
• Moolec Science's Liabilities and Shareholders Equity stood at $23.2 million in 2022, then declined by 8.01% to $21.3 million in 2023, then soared by 47.19% to $31.4 million in 2024, then surged by 229.49% to $103.4 million in 2025, then rose by 0.77% to $104.2 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $104.2 million (Q1 2026), $103.4 million (Q4 2025), and $204.7 million (Q2 2025), per Business Quant data.